Search results for "RNA therapy"

Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003

Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003

Rznomics, a biopharmaceutical company specializing in RNA-based gene therapies, announced on the 24th that it has received a decision to grant a U. S.
RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

Myocardial infarction and unstable angina are life-threatening medical emergencies that occur when the blood vessels supplying the heart muscle...
Cell and Gene Therapy Advances Take Center Stage at Samsung Joint International Symposium

Cell and Gene Therapy Advances Take Center Stage at Samsung Joint International Symposium

Leading researchers developing stem cell and extracellular vesicle therapies for sepsis, personalized mRNA vaccines for...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties

Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties

Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy

CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy

Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology

Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology

Rznomics announced on the 30th that a joint study with Professor Hyun-jin Kim’s research team at Inha University has...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...